Lakshmi Rajdev
ECOG-ACRIN Cancer Research Group · AIDS Malignancy Consortium · Montefiore Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lakshmi Rajdev as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:45 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05836584 · Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) CancerNational Cancer Institute (NCI) · active not recruiting · Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8 · principal investigator
- Ph3NCT03233711 · Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal CancerNational Cancer Institute (NCI) · active not recruiting · Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma · principal investigator
- Ph2NCT02893930 · Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by SurgeryNational Cancer Institute (NCI) · completed · Pancreatic Neuroendocrine Tumor G1, Pancreatic Neuroendocrine Tumor G2, Refractory Pancreatic Neuroendocrine Carcinoma · principal investigator
- Ph1NCT02408861 · Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryNational Cancer Institute (NCI) · terminated · Advanced Malignant Solid Neoplasm, Anal Carcinoma, HIV Infection · principal investigator
- Ph1/Ph2NCT02344810 · C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal CancerEastern Cooperative Oncology Group · withdrawn · Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach · principal investigator
- Ph2NCT00200395 · OSI-774 (Erlotinib, Tarceva) in Elderly PatientsMontefiore Medical Center · completed · Non-Small Cell Lung Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- ECOG-ACRIN Network Group Operations CenterU10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · fiscal years 2014 to 2026
- AIDS Malignancy Clinical Trials Consortium (AMC)U01CA121947 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RONALD T. MITSUYASU · fiscal years 2006 to 2014Named on NCT02408861
- Consortium for Advancing Management and Prevention of Cancer in People with HIVUM1CA121947 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Joseph A. Sparano · fiscal years 2015 to 2026Named on NCT02408861
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:45 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.J Clin Oncol · 2015481 citationsRCR 13.6
- Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.Lancet Oncol · 2022115 citationsRCR 7.5
- Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study.Clin Infect Dis · 202177 citationsRCR 4.0
- Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer.J Clin Oncol · 200162 citationsRCR 1.7
- Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.J Clin Oncol · 201755 citationsRCR 1.8
- Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancer.Clin Breast Cancer · 200425 citationsRCR 0.7
- Phase I trial of metronomic oral vinorelbine in patients with advanced cancer.Cancer Chemother Pharmacol · 201123 citationsRCR 0.6
- A phase I trial of intra lesional RV-B7.1 vaccine in the treatment of malignant melanoma.Hum Gene Ther · 200013 citationsRCR 0.3
- A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.Invest New Drugs · 202212 citationsRCR 0.9
- Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies.Am J Clin Oncol · 20028 citationsRCR 0.2